ARIAD To Present at Upcoming Investor Conferences
ARIAD To Present at Upcoming Investor Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- ARIAD Pharmaceuticals, Inc. (NAS: ARIA) today announced that it will provide an overview of the Company's business at two upcoming investor conferences being held next week:
The Morgan Stanley Global Healthcare Conference in New York City. Harvey J. Berger, M.D., chairman and chief executive officer, will present on Wednesday, September 11 at 1:30 p.m. (ET).
The Stifel Healthcare Conference in Boston. Timothy P. Clackson, Ph.D., president of research and development and chief scientific officer, will present on Wednesday, September 11 at 8:35 a.m. (ET).
Both presentations will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor. A replay of the presentation will also be available and archived on the site for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).
ARIAD Pharmaceuticals, Inc.
For Investors
Kendra Adams, 617-503-7028
Kendra.adams@ariad.com
or
For Media
Liza Heapes, 617-621-2315
Liza.heapes@ariad.com
KEYWORDS: United States North America Massachusetts New York
INDUSTRY KEYWORDS:
The article ARIAD To Present at Upcoming Investor Conferences originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
